两大知名药企,拟合并上市

赛柏蓝
Sep 28

2025年9月24日,中国证监会国际合作司发布亿腾医药境外发行上市备案通知书,亿腾医药拟通过与嘉和生物合并,实现在香港联合交易所上市,嘉和生物同时发行不超过18.84亿股境外上市普通股。此消息一出,又引起了业界对于两家药企合并上市的关注。01亿腾医药、嘉和生物拟合并上市早在2024年10月7日,嘉和生物发布公告称,公司与亿腾医药订立合并协议,嘉和生物将通过合并方式收购亿腾医药,合并后的新公司名称...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10